Average Co-Inventor Count = 3.56
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nimbus Lakshmi, Inc. (18 from 18 patents)
2. Concert Pharmaceuticals, Inc. (17 from 136 patents)
3. Amgen Inc. (8 from 1,970 patents)
4. Gilead Apollo, LLC (7 from 16 patents)
5. Nimbus Iris, Inc. (7 from 10 patents)
6. Nimbus Lakshimi, Inc. (6 from 6 patents)
7. Ajax Therapeutics, Inc. (5 from 5 patents)
8. Takeda Pharmaceutical Company Limited (3 from 1,177 patents)
9. Nimbus Apollo, Inc. (1 from 1 patent)
72 patents:
1. 12338242 - TYK2 inhibitors and uses thereof
2. 12275717 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
3. 12221453 - Substituted pyrazolo[5',1′:2,3]pyrimido[5,4-b][1,4]oxazines as TYK2 inhibitors
4. 12162881 - Forms and compositions of inhibitors of JAK2
5. 12043632 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
6. 11970494 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
7. 11834449 - TYK2 inhibitors and uses thereof
8. 11691963 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
9. 11434240 - TYK2 inhibitors and uses thereof
10. 11414431 - Substituted pyrazolo[1,5-a]pyrimidines as TYK2 inhibitors
11. 11396508 - TYK2 inhibitors and uses thereof
12. 11220508 - TYK2 inhibitors and uses thereof
13. 11174264 - TYK2 inhibitors and uses thereof
14. 11053241 - TYK2 inhibitors and uses thereof
15. 11046698 - TYK2 inhibitors and uses thereof